MedPath

Ultrasonic Treatment of Food Addiction

Phase 1
Withdrawn
Conditions
Obesity
Overweight
Interventions
Device: Sham stimulation with Diadem ultrasonic transducer array
Device: Active stimulation with Diadem ultrasonic transducer array
Registration Number
NCT06249711
Lead Sponsor
University of Utah
Brief Summary

This study will evaluate a new form of non-invasive deep brain therapy for food addiction. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled trial. The trial will evaluate brain target engagement using magnetic resonance imaging, Food Cravings Questionnaire-State, and changes in subject's weight over the course of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • History of at least one self-reported unsuccessful dietary effort to lose body weight
  • Body mass index more than or equal to 30 kg/m^2 or more than or equal to 25 kg/m^2 with the presence of at least one of the following weight-related comorbidities: hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease.
Exclusion Criteria
  • Lifetime history of a serious suicide attempt
  • MRI intolerance or contraindication
  • Pregnant or breast feeding
  • Diabetic (HbA1c more than 48 mmol/mol or 6.5%)
  • A self-reported change in body weight more than 10 lbs within 60 days before screening
  • Clinically inappropriate for participation in the study as determined by the study team

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham stimulationSham stimulation with Diadem ultrasonic transducer arrayZero-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction
Active stimulationActive stimulation with Diadem ultrasonic transducer arrayLow-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction
Primary Outcome Measures
NameTimeMethod
Change in body weight (%) from baseline week 0 to week 16The body weight will be taken prior to each intervention (once per week)

The body weight will be quantified with respect to baseline (100%), taken prior to the first intervention.

Number of participants who achieved body weight reduction >= 5%Assessment at week 16

Proportion of subjects who have lost at least 5% of their weight at week 16 relative to the baseline week 0.

Food Cravings Questionnaire-StateDuring and immediately after each weekly intervention

This 15-item questionnaire measures immediate level of food craving, each item ranging from 1 (strongly disagree) to 5 (strongly agree). Higher total scores indicate stronger desire to eat.

Hamilton Depression Rating Scale, 17 itemFor up to 16 weeks

This 17-item questionnaire measures the severity of depression. Scores range between 0 (least severe) to 52 (most severe).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Utah

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath